Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Quitkin

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Psychiatry Research|July 1, 1988
Lactate provocation of panic attacks in depressed outpatientsP J McGrath, J W Stewart, M R Liebowitz, et al.
Drug and Alcohol Dependence|October 1, 1995
Imipramine treatment of cocaine abuse: possible boundaries of efficacyE V Nunes, P J McGrath, F M Quitkin, et al.
Neurology|May 1, 1982
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessmentF Karoum, L W Chuang, T Eisler, et al.
The American Journal of Psychiatry|July 1, 1997
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter studyJ D Amsterdam, J Fawcett, F M Quitkin, et al.
Psychophysiology|March 21, 1998
Brain ERPs of depressed patients to complex tones in an oddball task: relation of reduced P3 asymmetry to physical anhedoniaG E Bruder, C E Tenke, J P Towey, et al.
Biological Psychiatry|May 1, 1997
Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic studyG E Bruder, R Fong, C E Tenke, et al.
The American Journal of Psychiatry|August 18, 1999
Changes in weight during a 1-year trial of fluoxetineD Michelson, J D Amsterdam, F M Quitkin, et al.
Journal of Clinical Psychopharmacology|February 1, 1994
Duration of antidepressant trials: clinical and research implicationsS J Donovan, F M Quitkin, J W Stewart, et al.
Journal of Clinical Psychopharmacology|December 1, 1993
Chronic depression: response to placebo, imipramine, and phenelzineJ W Stewart, P J McGrath, F M Quitkin, et al.
Archives of General Psychiatry|March 7, 1998
Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trialE V Nunes, F M Quitkin, S J Donovan, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Psychiatry Research|July 1, 1988
Lactate provocation of panic attacks in depressed outpatientsP J McGrath, J W Stewart, M R Liebowitz, et al.
Drug and Alcohol Dependence|October 1, 1995
Imipramine treatment of cocaine abuse: possible boundaries of efficacyE V Nunes, P J McGrath, F M Quitkin, et al.
Neurology|May 1, 1982
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessmentF Karoum, L W Chuang, T Eisler, et al.
The American Journal of Psychiatry|July 1, 1997
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter studyJ D Amsterdam, J Fawcett, F M Quitkin, et al.
Psychophysiology|March 21, 1998
Brain ERPs of depressed patients to complex tones in an oddball task: relation of reduced P3 asymmetry to physical anhedoniaG E Bruder, C E Tenke, J P Towey, et al.
Biological Psychiatry|May 1, 1997
Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic studyG E Bruder, R Fong, C E Tenke, et al.
The American Journal of Psychiatry|August 18, 1999
Changes in weight during a 1-year trial of fluoxetineD Michelson, J D Amsterdam, F M Quitkin, et al.
Journal of Clinical Psychopharmacology|February 1, 1994
Duration of antidepressant trials: clinical and research implicationsS J Donovan, F M Quitkin, J W Stewart, et al.
Journal of Clinical Psychopharmacology|December 1, 1993
Chronic depression: response to placebo, imipramine, and phenelzineJ W Stewart, P J McGrath, F M Quitkin, et al.
Archives of General Psychiatry|March 7, 1998
Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trialE V Nunes, F M Quitkin, S J Donovan, et al.
Pageof 16